Overview

Role of Bumetanide in Treatment of Autism

Status:
Recruiting
Trial end date:
2030-12-01
Target enrollment:
0
Participant gender:
All
Summary
Role of bumetanide in Autism
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Bumetanide
Criteria
Inclusion Criteria:

1. All patients with ASD diagnosed by CARS rating Scaleā©¾30.

2. Age of patients range between (3-12) years.

Exclusion Criteria:

- Patients with ASD associated with neurological antecedents (including epilepsies and
febrile seizures), hepatic, renal dysfunction or electrocardiogram abnormalities and
syndromatic children(Rett).